LifeStance Health (US:LFST)2025-11-05 23:41Financial Performance - Total revenue for Q3 2025 was $363.8 million, a 16% increase from $312.7 million in Q3 2024[3] - Net income for Q3 2025 was $1.1 million, compared to a net loss of $6.0 million in the prior year, representing a 118% improvement[4] - Adjusted EBITDA increased by 31% to $40.2 million, with an Adjusted EBITDA margin of 11.1%[6] - For the full year 2025, the company expects revenue between $1.41 billion and $1.43 billion, with Adjusted EBITDA guidance raised to $146 million to $152 million[12] - Total revenue for the three months ended September 30, 2025, was $363.8 million, a 16.4% increase from $312.7 million in the same period of 2024[21] - Net income for the three months ended September 30, 2025, was $1.1 million, compared to a net loss of $6.0 million in the same period of 2024[21] - Adjusted EBITDA for the nine months ended September 30, 2025, was $108.9 million, a 25.2% increase from $87.0 million in the same period of 2024[26] Operational Metrics - The clinician base grew by 11% to 7,996 clinicians, with a net increase of 288 clinicians in Q3 2025[4] - Visit volumes increased by 17% to 2.3 million in Q3 2025[4] - Center Margin for Q3 2025 was $116.6 million, representing 32.0% of total revenue, a 16% increase year-over-year[5] - Center margin for the three months ended September 30, 2025, was $116.6 million, compared to $100.4 million in the same period of 2024[24] Cash Flow and Debt - Net cash provided by operations was $27.3 million in Q3 2025, contributing to a strong cash position of $203.9 million[4] - Free Cash Flow for Q3 2025 was positive at $17.0 million[4] - Cash flows from operating activities for the nine months ended September 30, 2025, were $88.6 million, compared to $44.9 million in the same period of 2024[23] - Cash and cash equivalents at the end of the period on September 30, 2025, were $203.9 million, up from $102.6 million at the end of September 2024[23] - The company reported a net increase in cash and cash equivalents of $49.3 million for the nine months ended September 30, 2025[23] - The company ended Q3 2025 with net long-term debt of $269.4 million[7] Expenses - Operating expenses for the three months ended September 30, 2025, totaled $356.4 million, up from $312.7 million in the same period of 2024[21] - General and administrative expenses for the three months ended September 30, 2025, were $95.6 million, an increase from $85.3 million in the same period of 2024[21] - Depreciation and amortization for the nine months ended September 30, 2025, was $41.3 million, down from $56.3 million in the same period of 2024[23]